Sunday, 2nd August 2026
Khabor Wala Desk
Published: 2nd August 2026, 5:00 PM
SINGAPORE — FWD Insurance Singapore has introduced FWD MultiCover CI, a new critical illness policy providing multi-pay coverage and ongoing payouts rather than terminating after an initial claim.
The product rollout addresses changing healthcare dynamics in Singapore, where official health statistics reveal that the nation’s five-year cancer survival rate increased from 53% (2008–2012) to 61% (2019–2023). Over the same timeframe, cancer mortality declined from 91 to 72 deaths per 100,000 people. With patients surviving longer post-diagnosis, the insurer aims to address prolonged income disruption, ongoing caregiving costs, and long-term recovery expenses.
“For many families, the financial impact does not end with the first diagnosis,” said Adrian Vincent, CEO of FWD Insurance Singapore. “FWD MultiCover CI was created to reflect the realities of today’s critical illness journeys.”
FWD MultiCover CI covers up to 166 medical conditions across early, intermediate, and late stages. Subject to condition-specific sub-limits, policyholders can claim up to 900% of the total Sum Insured across all combined benefits.
| Feature / Benefit Tier | Coverage Details & Payout Limits | Waiting Period Requirements |
| Core Critical Illness Benefit |
• Up to 6 claims totaling 600% of Sum Insured
• Early / Intermediate stage: 100% payout
• Late stage: 200% payout |
1-year waiting period between claims |
| Booster Benefit |
• Additional 150% payout per claim for specified late-stage illnesses or recurrences
• Capped at 2 claims (up to 300% total) |
2-year waiting period between claims |
| Accelerated Care Option |
• Alternative option for late-stage diagnoses
• Receive an immediate 75% payout instead of retaining future booster benefits |
— |
| ICU Benefit | • Two-tier payout up to 120% of Sum Insured for severe hospital stays, even for conditions not explicitly listed in the policy | — |
The product is designed to provide recurring financial protection as medical advancements continue to extend life expectancy following critical health diagnoses.
Comments